Post-earnings recap
Reported
Wed, Nov 7, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Charles River Laboratories reported a strong earnings per share, exceeding expectations, which contributed to an 8.86% increase in stock price. The positive stock reaction reflects investor confidence in the company's performance and management's focus on innovation. However, the lack of revenue data and guidance leaves some uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.53 | N/A | +4.94% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the quarter's earnings performance. They emphasized their commitment to innovation as a key growth driver.
We are pleased with our performance this quarter.
Our focus on innovation continues to drive growth.